TG Therapeutics
TGTX
TGTX
181 hedge funds and large institutions have $2.33B invested in TG Therapeutics in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 74 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
3% more funds holding
Funds holding: 175 → 181 (+6)
1.28% more ownership
Funds ownership: 67.96% → 69.24% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
181
Holding in Top 10
5
Calls
$47.7M
Puts
$36.5M
Top Buyers
| 1 | +$114M | |
| 2 | +$98.3M | |
| 3 | +$88.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$54.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$33.2M |
Top Sellers
| 1 | -$106M | |
| 2 | -$46M | |
| 3 | -$45.3M | |
| 4 |
EP
Eversept Partners
New York
|
-$39.5M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$29.2M |